rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
1998-5-7
|
pubmed:abstractText |
Airway inflammation is a hallmark of asthma, therefore current treatment recommendations include the use of inhaled glucocorticosteroids (GCS). However, there is little evidence that the effects of inhaled GCS are dose dependent.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0091-6749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9564797-Adolescent,
pubmed-meshheading:9564797-Adult,
pubmed-meshheading:9564797-Aged,
pubmed-meshheading:9564797-Anti-Inflammatory Agents,
pubmed-meshheading:9564797-Asthma,
pubmed-meshheading:9564797-Budesonide,
pubmed-meshheading:9564797-Chronic Disease,
pubmed-meshheading:9564797-Dose-Response Relationship, Drug,
pubmed-meshheading:9564797-Double-Blind Method,
pubmed-meshheading:9564797-Female,
pubmed-meshheading:9564797-Humans,
pubmed-meshheading:9564797-Hydrocortisone,
pubmed-meshheading:9564797-Lung,
pubmed-meshheading:9564797-Male,
pubmed-meshheading:9564797-Middle Aged,
pubmed-meshheading:9564797-Nebulizers and Vaporizers
|
pubmed:year |
1998
|
pubmed:articleTitle |
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.
|
pubmed:affiliation |
University Hospitals CSC, Madison, WI, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|